FIELD: chemistry.
SUBSTANCE: invention relates to a compound CL168 of general structural formula I 
where R is oxygen. The invention also relates to a method of producing a compound of formula I and use of the compound of formula I to produce a medicinal agent for preventing or treating tumorous and immunological diseases.
EFFECT: compound of formula I for producing a medicinal agent for preventing or treating tumorous and immunological diseases.
4 cl, 11 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOVERED PEPTIDE STIMULATING ANTITUMOUR IMMUNE RESPONSE, BASED PHARMACEUTICAL COMPOSITION, METHOD OF TREATING MAMMAL AND METHOD OF IMMUNE RESPONSE MODULATION | 2002 |
|
RU2425053C2 |
| APPLICATION OF PROTEIN EXTRACT AS ANTIPROLIFERATIVE AND CYTOTOXIC AGENT | 2017 |
|
RU2671632C1 |
| PEPTIDE STIMULATING ANTITUMOR IMMUNE RESPONSE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD FOR TREATMENT OF MAMMAL AND METHOD FOR MODULATION OF IMMUNE RESPONSE | 2002 |
|
RU2305107C2 |
| AGENT FOR CANCER THERAPY | 2011 |
|
RU2471786C1 |
| THE USE OF CARRIMYCIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PRODUCTION OF MEDICINES FOR TREATMENT AND / OR TUMOR PREVENTION | 2018 |
|
RU2746047C1 |
| COMPOSITION CONTAINING PIC FOR CANCER TREATMENT | 2017 |
|
RU2728175C2 |
| POLYACYLATED DERIVATIVES OF 20(R)-GINSENOSIDE RG3, PRODUCTION AND USE THEREOF | 2018 |
|
RU2695380C1 |
| ANTICANCER PHARMACEUTICAL COMPOSITION (VERSIONS) AND APPLICATION THEREOF | 2005 |
|
RU2396274C2 |
| USE OF RECOMBINANT GANODERMA LUCIDUM IMMUNOMODULATORY PROTEIN (rLZ-8) IN PREPARATION OF MEDICINE FOR TREATING MELANOMA | 2014 |
|
RU2649129C2 |
| COMPOSITION FOR PREVENTING AND TREATING CANCER CONTAINING AGG ALBUMEN WITH COPPER VITRIOL | 2009 |
|
RU2473353C1 |
